1. Search Result
Search Result
Results for "

Cholesterol oxidase

" in MedChemExpress (MCE) Product Catalog:

13

Inhibitors & Agonists

2

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P2848
    Cholesterol oxidase, Microorganism
    2 Publications Verification

    ChOx

    Endogenous Metabolite Others
    Cholesterol oxidase, Microorganism (ChOx) is a bacterial flavin oxidase containing FAD, commonly used in biochemical research. Cholesterol oxidase catalyzes the oxidation of the C(3)-OH group of cholesterol (and other sterols) to cholest-5-en-3-one and isomerizes it to cholest-4-en-3-one .
    Cholesterol oxidase, Microorganism
  • HY-P2848A

    Toll-like Receptor (TLR) Infection Metabolic Disease
    Cholesterol oxidase, Rhodococcus sp. is a key enzyme in the cholesterol degradation process. It catalyzes the isomerization and oxidation of cholesterol mediated by the coenzyme FAD. Research indicates that cholesterol oxidase plays a crucial role in the pathogenicity of Mycobacterium tuberculosis by modulating the host macrophage immune response through inhibition of the Toll-like receptor 2 (TLR2) signaling pathway, thereby enhancing the survival of Mycobacterium tuberculosis. Cholesterol oxidase, from Rhodococcus sp., shows potential for research in the field of tuberculosis .
    Cholesterol oxidase, rhodococcus sp
  • HY-Y0106

    mTOR Xanthine Oxidase Apoptosis Cardiovascular Disease Metabolic Disease Inflammation/Immunology
    2,6-Dihydroxyacetophenone, a polyphenolic derivative of Acetophenone (HY-Y0989), is an orally active mTOR inhibitor. 2,6-Dihydroxyacetophenone shows antioxidant activity. 2,6-Dihydroxyacetophenone inhibits cell growth and proliferation in CRC cells. 2,6-Dihydroxyacetophenone arrests at G0/G1 phase of cell cycle, induces apoptosis and suppresses cell migration in CRC cells. 2,6-Dihydroxyacetophenone inhibits xanthine oxidase (XOD) with an IC50 of 1.24 mM. 2,6-dihydroxyacetophenone improves uric acid metabolism in hyperuricemia mice, reduces plasma cholesterol in hypercholesterolemic rats, and inhibits lipid accumulation in HFD-induced obese mice. 2,6-Dihydroxyacetophenone can be used for the study of colorectal cancer (CRC), hyperuricemia and hypercholesterolemia .
    2,6-Dihydroxyacetophenone
  • HY-P2879B

    Endogenous Metabolite Biochemical Assay Reagents Metabolic Disease
    Cholesterol esterase, Candida cylindracea is an enzyme located in the intestines that hydrolyzes cholesterol esters into cholesterol and free fatty acids. Also known as bile salt-stimulated lipase or carboxylester lipase, this enzyme facilitates cholesterol metabolism and absorption in the body. It can also be used as a biochemical reagent, and is employed in conjunction with cholesterol oxidase (HY-P2848) to measure cholesterol levels .
    Cholesterol esterase, Candida cylindracea
  • HY-175237

    Endogenous Metabolite Infection Inflammation/Immunology
    Cholesterol oxidase-IN-1 (Compound 4) is a Cholesterol oxidase inhibitor. Cholesterol oxidase-IN-1 has a superior binding affinity on cholesterol oxidase. Cholesterol oxidase-IN-1 can be used for infections and inflammatory diseases research .
    Cholesterol oxidase-IN-1
  • HY-P2848E

    Biochemical Assay Reagents Others
    Cholesterol oxidase, PEG Modified, is a polyethylene glycol (PEG) modified cholesterol oxidase. Cholesterol oxidase is an enzyme that catalyzes the oxidation of cholesterol to cholesterol-4-en-3-one and hydrogen peroxide in the presence of oxygen.
    Cholesterol oxidase, PEG Modified
  • HY-P2848C

    Endogenous Metabolite Metabolic Disease
    Cholesterol Oxidase, Pseudomonas sp. (EC 1.1.3.6) belongs to the oxidoreductase family, acts on the CH-OH group of the donor molecule, and uses oxygen as the acceptor. Cholesterol Oxidase, Pseudomonas sp. (EC 1.1.3.6) participates in the biosynthesis of bile acids.
    Cholesterol Oxidase, Pseudomonas sp.
  • HY-P2848D

    Biochemical Assay Reagents Others
    Cholesterol oxidase, Nocardia sp. (EC 1.1.3.6) is a monomeric flavoprotein containing FAD that catalyzes the first step in cholesterol catabolism.
    Cholesterol oxidase, Nocardia sp.
  • HY-E71037

    Biochemical Assay Reagents Others
    Chemically modified Cholesterol Oxidase, Brevibacterium species catalyzes the interconversion of cholesterol to cholest-4-en-3-one.
    Chemically modified Cholesterol Oxidase, Brevibacterium species
  • HY-P2848B

    Endogenous Metabolite Metabolic Disease
    Cholesterol Oxidase, Streptomyces sp. (EC 1.1.3.6) is a monomeric flavoprotein containing FAD that catalyzes the first step in cholesterol catabolism. This bifunctional enzyme oxidizes cholesterol to cholest-5-en-3-one in an FAD-requiring step, which is then isomerized to cholest-4-en-3-one with the release of H2O2.
    Cholesterol Oxidase, Streptomyces sp.
  • HY-19227

    PPAR Cardiovascular Disease
    BM 170249 is a peroxisome proliferator, particularly in the perivenous region of the central acini in the liver. BM 170249 significantly reduces serum triglyceride and cholesterol levels in rats. BM 170249 strongly induces the activity of key enzymes in the peroxisome fatty acid β-oxidation system (such as acyl-CoA oxidase AOX, multifunctional enzyme PH, and thiolase PT), but leads to decreased activity of catalase and uricase in peroxisome components. BM 170249 could be used in lipid-lowering studies .
    BM 170249
  • HY-Y0106R

    Reference Standards mTOR Xanthine Oxidase Apoptosis Cardiovascular Disease Metabolic Disease Inflammation/Immunology
    2,6-Dihydroxyacetophenone (Standard) is the analytical standard of 2,6-Dihydroxyacetophenone (HY-Y0106). This product is intended for research and analytical applications. 2,6-Dihydroxyacetophenone, a polyphenolic derivative of Acetophenone (HY-Y0989), is an orally active mTOR inhibitor. 2,6-Dihydroxyacetophenone shows antioxidant activity. 2,6-Dihydroxyacetophenone inhibits cell growth and proliferation in CRC cells. 2,6-Dihydroxyacetophenone arrests at G0/G1 phase of cell cycle, induces apoptosis and suppresses cell migration in CRC cells. 2,6-Dihydroxyacetophenone inhibits xanthine oxidase (XOD) with an IC50 of 1.24 mM. 2,6-dihydroxyacetophenone improves uric acid metabolism in hyperuricemia mice, reduces plasma cholesterol in hypercholesterolemic rats, and inhibits lipid accumulation in HFD-induced obese mice. 2,6-Dihydroxyacetophenone can be used for the study of colorectal cancer (CRC), hyperuricemia and hypercholesterolemia .
    2,6-Dihydroxyacetophenone (Standard)
  • HY-P2879C

    Endogenous Metabolite Metabolic Disease
    Cholesterol esterase, Schizophyllum commune is an enzyme that catalyzes the hydrolysis of cholesterol esters into free cholesterol and fatty acids, facilitating the absorption of cholesterol in the intestine. Cholesterol esterase, Schizophyllum commune can be used in combination with cholesterol oxidase to measure cholesterol content .
    Cholesterol esterase, schizophyllum commune

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: